AREAS OF EXCELLENCE

Immuno-oncology

With over 4,000 hematopoietic stem cell transplants performed, HMR is the largest transplant center in Quebec and one of the largest in Canada.

Grain
Image de présentation FHMR

Blood and bone marrow cancers

Immuno-oncology encompasses blood and bone marrow cancers, which are among the most diagnosed cancers. HMR is a beacon in Quebec for the investigation and treatment of this type of cancer.
Regular researchers in immuno-oncology at the Centre de recherche de l’Hôpital Maisonneuve-Rosemont.

18
Patients treated in 2023

14 844
Patients treated in 2023

160

The University Institute of Hemato-Oncology and Cellular Therapy.

Maisonneuve-Rosemont Hospital (HMR) is a pioneer in cellular therapy and stem cell treatments. It was within its walls that the first stem cell transplant took place. Today designated as the University Institute of Hemato-Oncology and Cellular Therapy, HMR is recognized worldwide for this expertise and receives patients from all over Canada.

If immuno-oncology was one of the first fields where this expertise could be used, this domain now extends across all areas of excellence at HMR.

« The advancements in immuno-oncology and cellular therapy would not have been possible without the contribution of the FHMR. »

« Thanks to the Donors of the Foundation, we have been able to advance research and push the boundaries of science. The advancements in immuno-oncology and cellular therapy would not have been possible without the contribution of the FHMR. »

Dr. Denis-Claude Roy

Dr. Denis-Claude Roy,Director of the University Institute of Hemato-Oncology and Cellular Therapy

Hôpital Maisonneuve-Rosemont

Anchored in the East since 1954, HMR is much more than a healthcare facility: it is a true institution at the heart of East Montreal and one of the largest hospital centers in Quebec. It provides care from birth to end-of-life for nearly 550,000 Montrealers.

Grain
Make a donation